Sandoz announced generic version of Latisse® brand in USA
Sandoz today declared the US market introduction of bimatoprost ophthalmic solution, 0.03% (0.3 mg/mL), which is a generic version of Allergan’s Latisse. Bimatoprost ophthalmic solution, 0.03%, is a prescription medicine indicated to treat hypotrichosis of the eyelashes by increasing their growth, including length, thickness, and darkness. “The launch of bimatoprost is a significant expansion to …
Sandoz announced generic version of Latisse® brand in USA Read More »